Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Launches Confidante®, the Only OTC Product Capable of Testing 10 STIs Simultaneously

Published: Monday, November 12, 2012
Last Updated: Monday, November 12, 2012
Bookmark and Share
Confidante® is a revolutionary new sexual health test. It is the only over-the-counter (OTC) product that can simultaneously detect 10 of the most common sexually transmitted infections (STI) in a single test.

Randox Laboratories, an international diagnostic solutions company headquartered in the UK, has launched Confidante® to offer a reliable and confidential solution for individuals who wish to test at home.

The latest Health Protection Agency (HPA) figures for STIs have shown a significant rise since 2010. For example, Gonorrhoea has increased by 25%, Syphilis by 5% and 1 in 14 people aged 16-24 have Chlamydia. It is clear to see that a reliable, easy to use, confidential test is greatly needed.

Confidante® from Randox offers a simple, accurate and confidential solution. Taking the test is straight-forward, customers just take either a urine or swab sample in the privacy of their own home and then send it to our laboratories for testing. The test comes with its own transport container and postage-paid envelope, ensuring convenience for the customer. Results are supplied directly to the customer via their chosen method (phone, email or post) within a few days. Unlike other products that can only test for 1 or 2 STIs, Confidante® is the first OTC product that allows customers to test for 10 commonly occurring STIs simultaneously in a single test. Confidante® tests for;

1)    Chlamydia trachomatis
2)    Neisseria gonorrhoea
3)    Treponema pallidum (Syphilis)
4)    Herpes Simplex Virus I
5)    Herpes Simplex Virus II
6)    Trichomonas vaginalis
7)    Mycoplasma hominis
8)    Mycoplasma genitalium
9)    Ureaplasma urealyticum
10)    Haemophilus ducreyi (Chancroid)

Confidante® is a cutting-edge testing procedure using molecular diagnostic technology that far exceeds other STI tests currently available. Our highly sensitive testing methods ensure results are extremely accurate. Confidante® allows individuals to take control of their sexual health in a convenient and confidential manner.

STIs spread quickly and easily through unprotected sex, however many STIs do not show any visible symptoms, making it difficult to tell who has one and who does not. Even though STI rates are increasing, many young people are now taking charge of their sexual health. They may decide to take a test for various reasons; if they notice symptoms, change their sexual partner, have unprotected sex or a partner who has tested positive for an STI. STIs which are left undetected or untreated can cause severe long term health problems, including infertility. There has never been a more important time for sexual health testing.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Randox Wins NI Hospital Trusts Business
Randox fought off global competition to win a five year contract to supply quality control products to the Northern Ireland Health & Social Care Trusts.
Monday, December 09, 2013
UK Trade and Investment Joins Hands with Randox
UK Trade and Investment organize healthcare seminars in Pakistan on “Improving Healthcare and Laboratory performance in Pakistan.”
Thursday, May 30, 2013
Newly Launched RIQAS Website Makes EQA Even Simpler for Laboratories Worldwide
www.riqas.com allows users to easily discover the many benefits offered by the world’s largest External Quality Assessment (EQA) scheme, Randox International Quality Assessment Scheme (RIQAS) and the advantages of implementing EQA in their laboratory.
Monday, March 04, 2013
You Don’t have to be a Scientist to Work in Healthcare
Randox is expanding its workforce with the recent recruitment of 42 individuals throughout October and November.
Thursday, November 15, 2012
Randox Opens New Manufacturing Facility in Bangalore, India
New Bangalore manufacturing facility to enhance product quality, ensure on time delivery and generate excellent customer satisfaction.
Friday, April 27, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!